冠状动脉旁路移植术患者围术期贫血防治的研究进展  

Research Advances in the Prevention and Treatment of Perioperative Anemia in Patients Undergoing Coronary Artery Bypass Grafting

作　　者：高原 高旭蓉 高洁 纪宏文 GAO Yuan;GAO Xurong;GAO Jie(Department of Blood Transfusion,Fuwai Hospital Chinese Academy of Medical Sciences,Beijing 100037)

机构地区：[1]中国医学科学院阜外医院输血科,北京100037 [2]中国医学科学院阜外医院麻醉科,北京100037

出　　处：《临床输血与检验》2023年第4期555-559,共5页Journal of Clinical Transfusion and Laboratory Medicine

基　　金：中国医学科学院医学与健康科技创新工程基金(No.2021-I2M-1-060)资助。

摘　　要：贫血会导致冠状动脉旁路移植术患者围术期输血率与输血量增加,住院时间延长,同时也是术后并发症率与死亡率的独立危险因素。患者血液管理是以患者为中心、基于循证和系统的方法,通过诊治围术期贫血和保护患者自体血液,以改善患者结局。本文对冠状动脉旁路移植术患者围术期贫血防治研究进展进行综述,希望对改进冠状动脉旁路移植术贫血患者治疗方案、改善患者临床结局有所裨益。Anemia leads to increased perioperative blood transfusion rate and blood transfusion volume,prolonged hospital stay in coronary artery bypass grafting patients,and is also an independent risk factor for postoperative complications and mortality.Patient blood management is a patient-centered,systematic,evidence-based approach to improve patient outcomes through the diagnosis and treatment of perioperative anemia and the protection of autologous blood.This paper reviews the research progress in the prevention and treatment of perioperative anemia in patients with coronary artery bypass grafting,which hopely improves the treatment plan and clinical outcome of patients with anemia after coronary artery bypass grafting.

关 键 词：贫血 冠状动脉旁路移植术 血液管理 

分 类 号：R457[医药卫生—治疗学]